Sugi Predict

Sugi Predict / Compounds / SCHEMBL4319897

SCHEMBL4319897

SCHEMBL4319897

O=C1c2ccc(Cl)cc2-c2cc(Cl)ccc21

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ S100A4 P26447 2/20 0.71
▸ HSP90AA1 P07900 1/20 0.57
▸ PPOX P50336 1/20 0.56
▸ CES1 P23141 2/20 0.50
▸ TGM2 P21980 1/20 0.50
▸ USP8 P40818 2/20 0.48
▸ USP7 Q93009 2/20 0.48
▸ METAP1 P53582 1/20 0.47
▸ PTPN1 P18031 1/20 0.46
▸ ITGA1 P56199 1/20 0.45
▸ USP47 Q96K76 1/20 0.44
▸ ESR1 P03372 1/20 0.44
▸ MAOA P21397 1/20 0.44
▸ UGT1A1 P22309 1/20 0.44
▸ MAOB P27338 1/20 0.44
▸ ESR2 Q92731 1/20 0.44
▸ MEN1 O00255 1/20 0.43
▸ CDC25B P30305 1/20 0.43
▸ KMT2A Q03164 1/20 0.43
▸ CHEK1 O14757 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29581505 1.00 S100A4 (0.71) S100A4HSP90AA1PPOXCES1TGM2
SCHEMBL11876117 0.94 S100A4 (0.80) S100A4HSP90AA1PPOXCES1TGM2
SCHEMBL353693 0.94 S100A4 (0.80) S100A4HSP90AA1PPOXCES1TGM2
SCHEMBL4229683 0.94 S100A4 (0.80) S100A4HSP90AA1PPOXCES1TGM2
SCHEMBL13030540 0.91 S100A4 (0.60) S100A4HSP90AA1PPOXCES1TGM2
SCHEMBL8675120 0.91 S100A4 (0.83) S100A4HSP90AA1PPOXCES1USP8
SCHEMBL30345128 0.89 S100A4 (0.90) S100A4HSP90AA1PPOXCES1TGM2
SCHEMBL1133148 0.89 S100A4 (0.90) S100A4HSP90AA1PPOXCES1TGM2
SCHEMBL155593 0.87 S100A4 (0.87) S100A4HSP90AA1PPOXCES1PTPN1
SCHEMBL29378883 0.87 S100A4 (0.87) S100A4HSP90AA1PPOXCES1PTPN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115433180-B Polycyclic compound and organic electroluminescent device thereof 武汉尚赛光电科技有限公司 2024-06-28 — — CN disclosed
US-11957687-B2 Modulators of HSD17B13 and methods of use thereof REGENERON PHARMACEUTICALS, INC. (US) 2024-04-16 — — US disclosed
CN-111465589-B Compound having fluorene skeleton and method for producing same 帝人株式会社 2024-01-05 — — CN disclosed
US-20230094341-A1 MODULATORS OF HSD17B13 AND METHODS OF USE THEREOF REGENERON PHARMACEUTICALS, INC. (US) 2023-03-30 — — US disclosed
CN-115433180-A Polycyclic compound and organic electroluminescent device thereof 武汉尚赛光电科技有限公司 2022-12-06 — — CN disclosed
EP-3994125-A1 MODULATORS OF HSD17B13 AND METHODS OF USE THEREOF Regeneron Pharmaceuticals, Inc. (US) 2022-05-11 — — EP disclosed
WO-2021003295-A1 MODULATORS OF HSD17B13 AND METHODS OF USE THEREOF REGENERON PHARMACEUTICALS, INC. (US) 2021-01-07 — — WO disclosed
WO-2021003295-A1 MODULATORS OF HSD17B13 AND METHODS OF USE THEREOF REGENERON PHARMACEUTICALS, INC. (US) 2021-01-07 — — WO disclosed
WO-2020226126-A1 COMPOUND HAVING FLUORENE SKELETON AND METHOD FOR PRODUCING SAME 帝人株式会社 2020-11-12 — — WO disclosed
CN-108191867-A A kind of thermal activation delayed fluorescence material and its application 中节能万润股份有限公司 2018-06-22 — — CN disclosed
US-20110112051-A1 Dipeptidyl Peptidase-IV Inhibitors ALANTOS PHARMACEUTICALS HOLDING, INC. (US) 2011-05-12 — — US disclosed
US-20100009961-A1 DIPEPTIDYL PEPTIDASE-IV INHIBITORS ALANTOS PHARMACEUTICALS HOLDING, INC. (US) 2010-01-14 — — US disclosed
US-20100009961-A1 DIPEPTIDYL PEPTIDASE-IV INHIBITORS ALANTOS PHARMACEUTICALS HOLDING, INC. (US) 2010-01-14 — — US disclosed
US-7635744-B2 Trifluorovinyloxy monomers and polymers GENERAL ELECTRIC COMPANY (US) 2009-12-22 — — US disclosed
US-7553861-B2 Dipeptidyl peptidase-IV inhibitors ALANTOS PHARMACEUTICALS HOLDING, INC. (US) 2009-06-30 — — US disclosed
US-7553861-B2 Dipeptidyl peptidase-IV inhibitors ALANTOS PHARMACEUTICALS HOLDING, INC. (US) 2009-06-30 — — US disclosed
US-20070238856-A1 Trifluorovinyloxy monomers and polymers GENERAL ELECTRIC COMPANY 2007-10-11 — — US disclosed
WO-2006116157-A9 DIPEPTIDYL PEPTIDASE-IV INHIBITORS ALANTOS PHARMACEUTICALS INC (US) 2007-03-01 — — WO disclosed
WO-2006116157-A2 DIPEPTIDYL PEPTIDASE-IV INHIBITORS ALANTOS PHARMACEUTICALS HOLDING, INC. (US) 2006-11-02 — — WO disclosed
US-4543190-A Processing methods for the oxidation of organics in supercritical water MODAR, INC. (US) 1985-09-24 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100009961-A1 DIPEPTIDYL PEPTIDASE-IV INHIBITORS DPP4, DPP3, DPP7 S100A4 3161/4885HSP90AA1 3282/4885PPOX 567/4885
US-20230094341-A1 MODULATORS OF HSD17B13 AND METHODS OF USE THEREOF HSD17B3, HSD17B11, HSD17B1 S100A4 4428/4885HSP90AA1 242/4885PPOX 2990/4885
US-11957687-B2 Modulators of HSD17B13 and methods of use thereof HSD17B3, HSD17B11, HSD17B1 S100A4 4428/4885HSP90AA1 242/4885PPOX 2990/4885
US-20110112051-A1 Dipeptidyl Peptidase-IV Inhibitors DPP4, DPP3, DPP7 S100A4 3161/4885HSP90AA1 3282/4885PPOX 567/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.